Dihydroergotamine and Respiratory syncytial virus immune globulin, human Intravenous
Determining the interaction of Dihydroergotamine and Respiratory syncytial virus immune globulin, human Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection)
Generic Name: respiratory syncytial virus immune globulin
Brand name:
Synonyms: Respiratory syncytial virus immune globulin, human (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine-RespiVent Dosepack DF
- Dihydroergotamine-Restall
- Dihydroergotamine-Restoril
- Dihydroergotamine-Retacrit
- Dihydroergotamine-Retapamulin
- Dihydroergotamine-Retapamulin topical
- Respiratory syncytial virus immune globulin, human Intravenous-Dihydroergotamine injection
- Respiratory syncytial virus immune globulin, human Intravenous-Dihydroergotamine Mesylate
- Respiratory syncytial virus immune globulin, human Intravenous-Dihydroergotamine nasal
- Respiratory syncytial virus immune globulin, human Intravenous-Dihydroergotamine Nasal Spray
- Respiratory syncytial virus immune globulin, human Intravenous-Dilacor XR
- Respiratory syncytial virus immune globulin, human Intravenous-Dilantin